Skip to main content
. 2021 Jun 25;8(1):311–318. doi: 10.14338/IJPT-D-20-00053

Table 1.

Patient and tumor characteristics (N = 11).

Patient
Age
Sex
Tobacco history
ECOG performance status
Histology
Diagnosis method
Recurrent
Prior RAI
Number of prior resections
Baseline Thyroglobulin
Post-treatment Thyroglobulin
1 64 M No 0 Papillary PET/CT Yes 2 2 38 3.5
2 64 F No 0 Papillary Biopsy Yes 1 2 2.4 2.0
3 56 F Yes 0 Hurthle cell Biopsy Yes 1 2 221 81
4 67 M Yes 1 Hurthle cell Biopsy Yes 1 2 44 0.3
5 50 F Yes 0 Papillary Biopsy Yes 6 4 255 111
6 55 M No 0 Papillary tall cell variant Biopsy Yes 1 2 396 Not available
7 55 F Yes 0 Hurthle cell Biopsy Yes 3 4 31 41
8 40 M Yes 0 Papillary Biopsy Yes 1 2 1.4 0.9
9 77 M Yes 1 Hurthle cell PET/CT Yes 1 2 112 21
10 67 M No 1 Papillary Biopsy Yes 1 2 121 3.9
11 72 M Yes 1 Poorly differentiated Biopsy Yes 1 3 101 1.2

Abbreviations: M, male; F, female; ECOG, Eastern Clinical Oncology Group; PET/CT, positron emission tomography/computed tomography; RAI, radioactive iodine.